Zobrazeno 1 - 10
of 185
pro vyhledávání: '"D. Münnich"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D, Münnich
Publikováno v:
Orvosi hetilap. 135(43)
Autor:
D, Münnich, F, Lehel
Publikováno v:
Therapia Hungarica (English edition). 38(1)
A total of 10 Shigella-positive and 10 Shigella-negative dysentery syndrome patients were treated with daily 2-g Gramurin doses for 3 days. Favourable clinical results could be obtained in response to the therapy. The complaints of the patients cease
Autor:
Beech, Nathan1 (AUTHOR) nathan.beech@awi.de, Rackow, Thomas2 (AUTHOR), Semmler, Tido3 (AUTHOR), Jung, Thomas1,4 (AUTHOR)
Publikováno v:
Geoscientific Model Development. 2024, Vol. 17 Issue 2, p529-543. 15p.
Autor:
Zhang, Di1 (AUTHOR) di.zhang@studium.uni-hamburg.de, Gade, Martin1 (AUTHOR) martin.gade@uni-hamburg.de, Wang, Wensheng2,3 (AUTHOR) wangws@aircas.ac.cn, Zhou, Haoran2,3 (AUTHOR)
Publikováno v:
Remote Sensing. Oct2023, Vol. 15 Issue 19, p4752. 18p.
Publikováno v:
Frontiers in Marine Science; 2024, p01-16, 16p
Autor:
Cui, Chaoran, Xu, Lingjing
Publikováno v:
Journal of Marine Science & Engineering; Oct2024, Vol. 12 Issue 10, p1743, 17p
Publikováno v:
Chemotherapy. 20:29-38
In 1972, 8 registered typhoid carriers and 1 carrier of Salmonella bareilly were treated with amoxycillin (Amoxil) and with Amoxil + probenecid in our department. All Salmo
Autor:
M.C.R. Quecedo, Nathan Clumeck, William D. Ball, Evelyn B. Perry, A. Rodríguez, D. Kaplan, P. de Mol, M. V. Vicente, S. Békési, Jan Verhoef, M. Rozenberg-Arska, D. Münnich, M P Vanderlinden, M.A.A.J. Beens-Dekkers, Edward O. Brissie, E. Yourassowsky, Michael D. Reed, J. P. Butzler, S.A.A. Duursma, Sean J. Fennell, G.Th.J. Fabius, Deborah M. Cooke, Leon D. Sabath, T. Olay, Raymond Vanhoof
Publikováno v:
Chemotherapy. 25:I-V
Autor:
M. Lakatos, D. Münnich
Publikováno v:
Chemotherapy. 20:113-119
130 patients with dysenteric syndrome were treated with Poteseptyl (trimethoprim + Superseptyl), among the 70 (54%) Shigella -positive patients. 70% of the infections were caused by